[A rare pulmonary lesion association]

M Mlika1, A Ayadi-Kaddour, A Marghli

  • 1Service d'Anatomie Pathologique, Hôpital Abderrahman Mami, Ariana, Tunisie. mlika.zorgati.mona@hotmail.com

Abstract

Insights

Localized pulmonary amyloidosis associated with MALT lymphoma is rare in Gougerot-Sjögren syndrome. This rare association may have a better prognosis than disseminated amyloidosis.

Area of Science:

  • Pulmonology
  • Oncology
  • Immunology

Background:

  • Pulmonary amyloidoma, a localized form of amyloidosis, can mimic lung cancer.
  • It may be linked to infections, systemic diseases, or lymphomas.

Observation:

  • A 36-year-old patient with diabetes, hypothyroidism, and Gougerot-Sjögren syndrome presented with respiratory symptoms.
  • Imaging revealed bilateral pulmonary nodules and mediastinal lymphadenopathy.
  • Biopsy showed nodular pulmonary amyloidosis with MALT lymphoma and parenchymal destruction.

Findings:

  • Histochemical and immunohistochemical studies confirmed the co-occurrence of nodular pulmonary amyloidosis and MALT pulmonary lymphoma.
  • This occurred in the context of Gougerot-Sjögren syndrome.

Implications:

  • The association of MALT pulmonary lymphoma and localized amyloidosis is rare in Gougerot-Sjögren syndrome.
  • The pathogenesis is unknown, and management is not standardized due to rarity.
  • Localized amyloidosis with MALT lymphoma may indicate a better prognosis than disseminated amyloidosis.

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.8K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
724
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
535
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.9K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K